Updated with new information on the effectiveness of HBOT to treat Traumatic Brain Injury (TBI), The Oxygen Revolution proves a powerful resource for knowledge of this unique therapeutic modality.
Research has shown that HBOT directly affects the body at the genetic level, affecting over 8,000 individual genes—those responsible for healing, growth, and anti-inflammation.
Leading expert Dr. Paul G. Harch’s research and clinical practice has shown that HBOT’s noninvasive and painless treatment can help those suffering from Traumatic Brain Injury (TBI) or such diseases as stroke, autism, cerebral palsy, Alzheimer’s, Parkinson’s disease, multiple sclerosis, and emergency situations requiring resuscitation, such as cardiac arrest, carbon monoxide poisoning, or near drowning.
For those affected by these seemingly “hopeless” diseases, there is finally hope in a proven solution: HBOT.
ABOUT THE AUTHOR
Paul G. Harch, M.D. is a hyperbaric medicine, diving, and emergency medicine physician and Diplomate of the American Board of Hyperbaric Medicine. The first President of the International Hyperbaric Medical Association and a semi-finalist for the National Institutes of Health Director’s Pioneer Award, he has seen the positive effects of HBOT firsthand through the treatment of family members with stroke, dementia, and learning disability. A graduate of Johns Hopkins University School of Medicine and Director of the Louisiana State University School of Medicine’s Hyperbaric Medicine Department, Dr. Harch currently divides his time between international consulting, lecturing, and his practice and research in the New Orleans area. Visit him at www.HBOT.com.
THE OXYGEN REVOLUTION, THIRD EDITION
Written by Paul G. Harch, MD and Virginia McCullough
978-1-57826-627-2, $19.95 paperback
978-1-57826-628-9, $15.99 ebook
In stores April 26, 2016.
New from Hatherleigh Press.
Available wherever books are sold.
